Generation Bio Co. (GBIO)

0.45

-0.01 (-1.29%)

At close: Mar 27, 2025, 3:59 PM

0.47

5.43%

After-hours: Mar 27, 2025, 07:52 PM EDT

Company Description

Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases.

The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina.

It also focuses on the diseases of skeletal muscle, central nervous system, and oncology.

The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017.

Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Generation Bio Co.

Country	United States
IPO Date	Jun 12, 2020
Industry	Biotechnology
Sector	Healthcare
Employees	115
CEO	Dr. Cameron Geoffrey McDonough M.D.

Address: 301 Binney Street Cambridge, Massachusetts United States
Website	https://generationbio.com

Name	Position
Dr. Cameron Geoffrey McDonough M.D.	President, Chief Executive Officer & Director
Antoinette Paone M.B.A., M.S.	Chief Operating Officer
Kevin John Conway	Chief Financial Officer
Yalonda Howze J.D.	Chief Legal Officer & Secretary
Caitlin Cooper M.B.A.	Senior Vice President & Head of Business Development
Dr. Mark D. Angelino Ph.D.	Co-Founder
Dr. Phillip Samayoa Ph.D.	Chief Scientific Officer
Dr. Robert Kotin Ph.D.	Co-Founder
Jasmin Tower	Chief Human Resources Officer